Physician profile
Joel Nutt
NPI 1265720791
$1,153.75
in general payments reported to CMS, 2019-2025
9 companies · $398 in 2025
The $398 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $90.42 · 2021: $316 · 2022: $29.22 · 2023: $80.40 · 2024: $75.58 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303 · Travel and Lodging: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.98 |
| Travel and Lodging | $251.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $528.30 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Stryker Corporation | $280.68 | 2025 | Mild Device Kit |
| Pfizer INC. | $180.98 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $42.80 | 2019 | |
| Medtronic, INC. | $34.52 | 2022-2023 | Intellis Adaptivestim |
| Pacira Pharmaceuticals Incorporated | $28.98 | 2023 | Iovera, Zilretta, Exparel |
| Ambu INC. | $26.97 | 2025 | |
| Grt US Holding, INC. | $18.23 | 2021 | |
| Collegium Pharmaceutical, INC. | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Nutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.